Paid Social Creative for GLP-1 and Weight Loss Telehealth Brands
We build compliant, performance-tested ad creative for GLP-1 telehealth brands. Semaglutide, tirzepatide, and weight loss prescription products. Every angle, format, and hook tested for your market.
GLP-1 advertising is the highest-stakes vertical in telehealth right now. Massive demand. Intense competition. FDA scrutiny on every claim. Meta rejections on before/after content. Brands spending $200K+/month on ads and burning creative faster than they can produce it. You need specialized creative that understands GLP-1 patient psychology, knows the compliance landmines, and can produce at the volume your ad account demands.
Proven approaches.
Problem → Solution
Lead with the weight loss struggle. Position GLP-1 as the breakthrough that finally works. Emphasize medical supervision and prescription-grade treatment.
Social Proof
Real patient testimonials (compliant). Results-focused but avoids specific weight loss numbers. Focuses on how they feel, not just how they look.
Doctor Authority
Credentialed physician explains how GLP-1 works, why it's different, and what patients can expect. Builds trust and positions as medical treatment, not diet trend.
Convenience Angle
At-home treatment, no in-person visits, delivered to your door. Positions telehealth as the easier path to GLP-1 access.
Formats We Produce
What gets GLP-1 ads rejected.
What We Review
Every script, claim, and visual reviewed against FDA, FTC, and platform policies before delivery.
- Weight loss claims without FDA-approved language
- Before/after imagery that violates FTC substantiation rules
- Comparisons to brand-name drugs (Ozempic, Wegovy, Mounjaro)
- Medical claims about diabetes, cardiovascular benefits, or off-label uses
- Testimonials without proper disclaimers
- Pricing or promotional language that triggers platform review
READY TO BUILD CREATIVE THAT CONVERTS?
Book a 30-minute strategy call. We'll show you exactly what a complete creative testing architecture looks like for your vertical.
Get in Touch